Valeritas’ V-Go Shows Enhanced Clinical Benefits in Patients with Uncontrolled T2 Diabetes Previously Treated with Daily Injections

Valeritas V-Go
Image: Valeritas
Valeritas, a Bridgewater, NJ-based medical technology company, announced that its V-Go, a wearable insulin delivery system has shown improved clinical benefits in patients with uncontrolled type 2 diabetes previously treated with multiple daily injections (MDIs) at the Metabolic & Endocrine Disease Summit (MEDS) conference in San Diego, California. The study showed that insulin-dependent patients with […]